Assessment of doxorubicin toxicity using human cardiac organoids: A novel model for evaluating drug cardiotoxicity

Cancer treatment and survivorship statistics, 2022

Kimberly D. Miller, Letícia Nogueira, Theresa P. Devasia et al. · CA A Cancer Journal for Clinicians · 2022 · 3.7K citations · Full text

Medicine, Oncology, Population Health Sciences +17

Cells of the adult human heart

Monika Litviňuková, Carlos Talavera‐López, Henrike Maatz et al. · Nature · 2020 · 1.8K citations · Full text

Life Sciences, Cardiology, Cell Biology +17

Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations

Giuseppe Curigliano, Daniel J. Lenihan, Michael G. Fradley et al. · Annals of Oncology · 2020 · 1K citations · Full text

Medicine, Cardiology, Oncology +17

Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement

Joerg Herrmann, Daniel J. Lenihan, Saro H. Armenian et al. · European Heart Journal · 2021 · 595 citations · Full text

Medicine, Cardiology, Oncology +16

Self-assembling human heart organoids for the modeling of cardiac development and congenital heart disease

Yonatan R. Lewis‐Israeli, Aaron H. Wasserman, Mitchell A. Gabalski et al. · Nature Communications · 2021 · 486 citations · Full text

Life Sciences, Cell Biology, Developmental Biology +17